DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20163261

Study of prescribing pattern of topical corticosteroids in dermatology out patients department in a tertiary care hospital in India

Rajan P. Nerurkar, Manish R. Kokane, Manthan Nikesh Mehta

Abstract


Background: The selection of rational yet most effective treatment is an art to be learnt by most physicians. The advent of topical glucocorticoids has changed the way inflammatory dermatological conditions are managed. However, there is a constant need to keep a check on these prescriptions for their rationality. The present study was done to review the prescribing pattern of topical corticosteroids in dermatology outpatients at a tertiary care hospital.

Methods: This was a prospective observational study on 300 prescriptions of patients above 18 years of age receiving topical corticosteroids in the dermatological outpatient department of a tertiary care hospital in the time frame of June 2014 to August 2014. Data obtained was recorded in a structured case record form (CRF) and analysed for their prescribing pattern, adverse reactions and cost analysis within different socioeconomic classes. Data was analysed using relevant statistical tests. A P-value of less than 0.05 was considered significant.

Results: Data was collected from 300 patients with the mean age of 38.28±11 years. The most common indication for prescription of topical steroids was eczema (22.33%). The most commonly prescribed topical steroid was clobetasol (68.66%) followed by mometasone (11%), betamethasone (9.33%) and halobetasol (3%). Cream was the most frequently prescribed formulation (85.66%). 28 patients (9.33%) out of 300 showed adverse drug reactions, of which, erythema was the most common (50%).

Conclusions: Topical corticosteroids are effective drugs in an array of dermatological diseases and abundant choices are available in different formulations. Optimal therapy involves careful consideration of factors such as potency, formulation, responsiveness and the cost of the topical steroid.


Keywords


Drug utilization, Skin conditions, Cost analysis, Prescriptions, Adverse events

Full Text:

PDF

References


World Health Organization. Introduction to drug utilization research (online). Oslo, Norway: World Health Organization; 2003. Available at http://apps.who.int/medicinedocs/pdf/s4876e/s4876e.pdf. Accessed on 30 February 2016.

Ritter JM, Lewis LD, Timothy GKM, Ferro A. Drugs and the skin. A textbook of clinical pharmacology and therapeutics, 5th edition, London, Hodder Arnold; 2008:411-419.

Werth VP. Systemic corticosteroids. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest DA, Paller AS, Leffel DJ (Eds.). Fitzpatrick’s Dermatology in General Medicine. 7th edn. Newyork, MC Graw Hill; 2008:2147.

World Health Organization. WHO Model list of Essential Medicines. 17th edition, 2011. Available at http://www.whoindia.org/Linkfiles/ Essential_ Medicines_List_EML17.pdf. Accessed on 23 February 2016.

Kumar BP, Dudala RS, Rao AR. Kuppuswamy’s socioeconomic status scale- a revision of economic parameter for 2012. International journal of research and development of health. 2013;1:2-4.

Kumar AM, Noushad PP, Shailaja K, Jayasutha J, Ramasamy C. A study on drug prescribing pattern and use of corticosteroids in dermatological conditions at a tertiary care teaching hospital. International Journal of Pharmaceutical Sciences Review and Research. 2011;9:132-5.

Narwane SP, Patel TC, Shetty YC, Chikhalkar SB. Drug utilization and cost analysis for common skin diseases in dermatology OPD of an Indian Tertiary Care Hospital-A Prescription Survey. British Journal of Pharmaceutical Research. 2011;1:9-18.

Divyashanthi CM, Manivannan E. Prescribing analysis of corticosteroids among the dermatology in-patients in a tertiary care teaching hospital, Karaikal, Puducherry. Int J Pharm Bio Sci. 2014;5:324-30.

Stern RS. The pattern of topical corticosteroid prescribing in the United States, 1989-1991. J Am Acad Dermatol. 2006;35:183‑6.

Walsh P, Aeling JL, Huff L, Weston WL. Hypothalamus pituitary- adrenal axis suppression by superpotent topical steroids. J Am Acad Dermatol. 1993;29:501‑3.

Kshirsagar MJ, Langade D, Patil S, Patki PS. Prescribing patterns among medical practitioners in Pune, India. Bull. World Health Organization. 1998;76:271-5.

Rathod SS, Motghare VM, Deshmukh VS, Deshpande RP, Bhamare CG, Patil JR. Prescribing practices of topical corticosteroids in the outpatient dermatology department of a rural tertiary care teaching hospital. Indian J Dermatol. 2013;58:342-5.

Sweileh WM. Audit of prescribing practices of topical corticosteroids in outpatients dermatology clinics in North Palestine. Eastern Mediterranean Health Journal. 2006;12:161-69.

Gupta N, Sharma D, Garg SK, Bhargava VK. Auditing of prescriptions to study utilization of antimicrobials in a tertiary hospital. Ind J Pharmacol. 1997;29:411-5.